Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) causes severe acute
respiratory syndrome. mRNA vaccines directed at the SARS-CoV-2 spike protein resulted in …

Functional delivery of mRNA has high clinical potential. Previous studies established that
mRNAs can be delivered to cells in vitro and in vivo via RNA-loaded lipid nanoparticles …

Abstract Coronavirus disease 2019 (COVID‑19) is a global pandemic that can have a long‑
lasting impact on public health if not properly managed. Ongoing vaccine development trials …

In late 2019, a novel coronavirus named severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) emerged in Wuhan, China. SARS‐CoV‐2 and the disease it causes …

The first two mRNA vaccines against infection by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) that were approved by regulators require a cold chain and …

In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-
derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …

Simple Summary Extracellular vesicles (EVs) allow cell-to-cell communication and can
induce a strong immune response, by presenting antigens. EVs can be engineered to …

Extracellular vesicles (EVs) are released by most cell types as part of an intracellular
communication system in crucial processes such as inflammation, cell proliferation, and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) …

Objectives Nearly three years into the pandemic, SARS-CoV-2 infections are occurring in
vaccinated and naturally infected populations. While humoral and cellular responses in …